Skip to content

Drug interactions

Infliximab + Meningococcal a c y and w-135 polysaccharide vaccine combined

Severity: Minor

Infliximab and Meningococcal a c y and w-135 polysaccharide vaccine combined: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

This is a non-live vaccine, so there is no risk of vaccine-strain infection. Infliximab may reduce the antibody response, though vaccination is still recommended.

What this interaction means in plain words

Infliximab and Meningococcal a c y and w-135 polysaccharide vaccine combined have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

TNF blockade-related immunosuppression may modestly reduce vaccine antibody responses.

What to do

Vaccinate as indicated, preferably before starting infliximab. Do not withhold infliximab for the vaccination.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Infliximab and Meningococcal a c y and w-135 polysaccharide vaccine combined, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Infliximab with Meningococcal a c y and w-135 polysaccharide vaccine combined?

MediHelp rates the interaction as minor. Infliximab and Meningococcal a c y and w-135 polysaccharide vaccine combined have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. This is a non-live vaccine, so there is no risk of vaccine-strain infection. Infliximab may reduce the antibody response, though vaccination is still recommended.

How serious is the interaction between Infliximab and Meningococcal a c y and w-135 polysaccharide vaccine combined?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate as indicated, preferably before starting infliximab. Do not withhold infliximab for the vaccination.

What other medicines interact with Infliximab?

MediHelp also lists interactions of Infliximab with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine. The full list is on the Infliximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in